Does RIMABOTULINUMTOXINB Cause Off label use? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Off label use have been filed in association with RIMABOTULINUMTOXINB (Myobloc). This represents 8.5% of all adverse event reports for RIMABOTULINUMTOXINB.
15
Reports of Off label use with RIMABOTULINUMTOXINB
8.5%
of all RIMABOTULINUMTOXINB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Off label use From RIMABOTULINUMTOXINB?
Of the 15 reports, 1 (6.7%) resulted in death, 6 (40.0%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIMABOTULINUMTOXINB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does RIMABOTULINUMTOXINB Cause?
Death (34)
Product use in unapproved indication (32)
Dysphagia (17)
Dry mouth (15)
Drug ineffective (14)
Atypical mycobacterial infection (11)
Headache (10)
Nausea (9)
Asthenia (7)
Dizziness (7)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RIMABOTULINUMTOXINB Alternatives Have Lower Off label use Risk?
RIMABOTULINUMTOXINB vs RIMEGEPANT
RIMABOTULINUMTOXINB vs RIOCIGUAT
RIMABOTULINUMTOXINB vs RIPRETINIB
RIMABOTULINUMTOXINB vs RISANKIZUMAB
RIMABOTULINUMTOXINB vs RISANKIZUMAB-RZAA